AMENDMENT TO POLISH REGULATIONS – EASIER RULES TO FACILITATE THE CULTIVATION OF HEMP AND POPPY SEEDS
May 7, 2022 marked the introduction of the amendment to the Polish Act on Counteracting Drug Addiction. The amendments to the Polish regulations make it possible to cultivate non-fiber hemp, carried out in research institutes, in order to obtain the raw material intended for the preparation of drugs. The act also transfers the obligation to monitor the cultivation of poppy and fibrous hemp from local government authorities to the National Center for Agricultural Support.
The cultivation of hemp and poppy seeds in Poland is a controlled sector. The current legal status contains regulations according to which the producer and the buyer of poppy or hemp annually submitted an application, together with all the documentation, to the relevant authorities (mayors, city presidents) or voivodeship marshals for a decision authorizing the cultivation or purchase of poppy or fiber hemp. The new solutions abolish these requirements. To be able to grow hemp or poppy, one will only need to submit an application to the National Center for Agricultural Support. Additionally, on the basis of the current regulations, the voivodship parliament is responsible for determining the area of poppy and hemp. This solution had a limiting effect on the cultivation area and the development opportunities of the national bioeconomy. The new regulations abolish this obligation. In addition, the catalog of destination and purposes for which poppy or industrial hemp can be used is to be expanded.
The new act transfers the obligation to monitor the cultivation of poppy and fibrous hemp from commune heads (mayors, city presidents) competent for the location of the cultivation to the National Center for Agricultural Support. It is proposed that purchase monitoring should also be carried out by the National Center for Agricultural Support (currently the monitoring of purchase is carried out by marshal offices). Entities that will grow poppy or industrial hemp will be entered in the register kept by the director of the appropriate local branch of the National Center for Agricultural Support. In addition, the act will include a provision obliging the National Center for Agricultural Support to carry out inspections of poppy or hemp producers and buyers, control of information contained in applications and control of poppy and fiber hemp cultivation.
The new regulations stipulate that checks must be performed on at least 10 percent of poppy producers and 10 percent of hemp producers in a given harvest year.
The cultivation of poppy and hemp can be carried out for the following purposes: energy, veterinary, fodder, composite materials, reclamation, beekeeping, fertilizing, as natural plant protection products. In addition, the project proposes that poppy and industrial hemp could also be grown for own needs, scientific and research purposes, and for the cultivation of new varieties of poppy and fiber hemp.
- On May 10th and May 11th, KIELTYKA GLADKOWSKI KG LEGAL participates in the US Chamber of Commerce second annual virtual Global Forum. This year’s theme is “Competition in the Global Marketplace.” The speakers will discuss substantial shifts in the global landscape and explore how the competition for global markets has shifted and how today’s decisions […]
- AMENDMENT TO POLISH REGULATIONS – EASIER RULES TO FACILITATE THE CULTIVATION OF HEMP AND POPPY SEEDSMay 7, 2022 marked the introduction of the amendment to the Polish Act on Counteracting Drug Addiction. The amendments to the Polish regulations make it possible to cultivate non-fiber hemp, carried out in research institutes, in order to obtain the raw material intended for the preparation of drugs. The act also transfers the obligation to […]
- On October 13, 2022, there will enter into force changes to the Polish Commercial Companies Code, which will have influence on corporations operating in Poland, particularly from the perspective of holding law, regulations increasing the powers of supervisory boards and imposing additional obligations on the management boards of capital companies. The changes are introduced by […]
- On 5 May 2022 KIELTYKA GLADKOWSKI KG LEGAL participated in the meeting organized by Life Science Cluster on material engineering. The main speakers were the representatives of the Institute of Metallurgy and Materials Science of the Polish Academy of Sciences in Krakow. The Institute of Metallurgy and Materials Science deals with issues from the border […]
- Drones – how dangerous can they be? The dangers of drones are no longer just a question of military use. The ease of acquiring and controlling drones as well as the possibility to test invented tasks in advance means that small flying devices are already used not only by the military. Currently, they are becoming […]
- From May 1, 2022 in Poland adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least two lines of systemic treatment will receive funding for the novel CAR-T (tisagenlecleucel) therapy. CAR-T is a breakthrough in the treatment of hematology patients. The mechanism of action of this therapy is completely different from […]
- Polish data protection authority announced the launch of inspections regarding compliance with regulations concerning data protection officers and published questions to be asked by the Polish authority in the course of such inspections. From the beginning of the application of the provisions of the GDPR, the Polish Office for Personal Data Protection, both as part […]
- On 1 April 2022, the European Parliament’s Committee on Economic and Monetary Affairs (ECON) published a report setting out its proposed amendments to the draft regulation on information accompanying transfers of funds and certain crypto-assets (recast). The draft report puts forward the following key proposals: 1. No exemptions based on the value of the transfer: […]
- What are generic drugs? Patent protection for a newly introduced drug on the market lasts almost 20 years. During this time, no other company (except the one with the patent) has the right to produce it. When protection ends, the drug may be manufactured by other manufacturers who begin to compete with each other – […]
- KIELTYKA GLADKOWSKI humbly boasts its success. We have been ranked in the Legal500 EMEA 2022 ranking in the following categories: Data privacy and data protection Private client Healthcare and life sciences Our entire team is very grateful to all our Clients for reviews and assessment. The success would not be possible without our Clients. […]
